NDUFS4 and melanoma: Consistent with facts that NDUFS4 mediated oxidative metabolism acts as a barrier to the response of PD-1 blockade in melanoma (Najjar et al., 2019), and more and more studies convey the concept that tumor cell metabolites epigenetically regulate the immune cell phenotype (Jiang et al., 2020).